(ZZ-B) Zinzino Series - Ratings and Ratios
Dietary Supplements, Skincare Products, Coffee, Health Tests
ZZ-B EPS (Earnings per Share)
ZZ-B Revenue
Description: ZZ-B Zinzino Series
Zinzino AB (publ) is a direct sales company that offers a range of dietary supplements and skincare products globally, operating through two segments: Zinzino and Faun. The companys product portfolio includes skincare products, such as cleansers and face creams, as well as dietary supplements focused on immune health, omega supplements, and gut health.
From a business perspective, Zinzinos revenue growth and profitability are key performance indicators (KPIs) to monitor. With a Return on Equity (RoE) of 50.93%, the company demonstrates a strong ability to generate profits from shareholder equity. The companys market capitalization stands at 9674.17M SEK, indicating a significant presence in the market. The Price-to-Earnings (P/E) ratio of 49.51 suggests that the stock may be relatively expensive compared to its earnings, potentially indicating high growth expectations.
To further analyze Zinzinos performance, additional KPIs such as revenue growth rate, gross margin, and operating margin can be examined. A high revenue growth rate would indicate the companys ability to expand its customer base and increase sales. A stable or increasing gross margin would suggest that the company is able to maintain its pricing power and manage its cost of goods sold effectively. Furthermore, an analysis of the companys sales channels, including online sales, can provide insights into its distribution strategy and potential areas for growth.
From a valuation perspective, it is essential to consider Zinzinos financial health and compare it to industry peers. By examining metrics such as the debt-to-equity ratio, interest coverage ratio, and dividend yield, a more comprehensive understanding of the companys financial stability and potential for future growth can be gained. As Zinzino operates in the competitive direct sales industry, monitoring its market share and competitive positioning is also crucial.
Additional Sources for ZZ-B Stock
ZZ-B Stock Overview
Market Cap in USD | 990m |
Sector | Consumer Defensive |
Industry | Packaged Foods |
GiC Sub-Industry | Packaged Foods & Meats |
IPO / Inception |
ZZ-B Stock Ratings
Growth Rating | 80.3 |
Fundamental | 79.1 |
Dividend Rating | 78.7 |
Rel. Strength | 184 |
Analysts | - |
Fair Price Momentum | 296.29 SEK |
Fair Price DCF | 197.15 SEK |
ZZ-B Dividends
Dividend Yield 12m | 2.29% |
Yield on Cost 5y | 16.26% |
Annual Growth 5y | 40.40% |
Payout Consistency | 97.8% |
Payout Ratio | 78.1% |
ZZ-B Growth Ratios
Growth Correlation 3m | 87.3% |
Growth Correlation 12m | 96% |
Growth Correlation 5y | 52.8% |
CAGR 5y | 57.75% |
CAGR/Max DD 5y | 0.83 |
Sharpe Ratio 12m | 3.22 |
Alpha | 213.85 |
Beta | 0.363 |
Volatility | 70.44% |
Current Volume | 97.6k |
Average Volume 20d | 128.9k |
Stop Loss | 225.1 (-7%) |
As of August 03, 2025, the stock is trading at SEK 242.00 with a total of 97,633 shares traded.
Over the past week, the price has changed by +3.86%, over one month by -0.21%, over three months by +42.07% and over the past year by +229.61%.
Yes, based on ValueRay´s Fundamental Analyses, Zinzino Series (ST:ZZ-B) is currently (August 2025) a good stock to buy. It has a ValueRay Fundamental Rating of 79.10 and therefor a positive outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of ZZ-B is around 296.29 SEK . This means that ZZ-B is currently undervalued and has a potential upside of +22.43% (Margin of Safety).
Zinzino Series has no consensus analysts rating.
According to our own proprietary Forecast Model, ZZ-B Zinzino Series will be worth about 329.8 in August 2026. The stock is currently trading at 242.00. This means that the stock has a potential upside of +36.29%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | 187 | -22.7% |
Analysts Target Price | - | - |
ValueRay Target Price | 329.8 | 36.3% |